Reply to Antisense oligonucleotide targeting Bcl-2 mRNA in cancer; bad drug, bad target, neither or both?
Academic Article
Publication Date:
2009
abstract:
Not applicable
Iris type:
01.01 Articolo in rivista
Keywords:
melanoma; BCL-2
List of contributors:
Palmieri, Giuseppe
Published in: